Skip to main content
SpringerLink
Log in

Efficacy of intravenous disopyramide in acute cardiac arrhythmias

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure. Disopyramide 50 mg was administered in a few seconds and any remaining dose within 2 to 5 min. The overall success rate was 80.5%. Intravenous disopyramide was more effective in patients with ventricular arrhythmias (85%) than in those with supraventricular arrhythmias (76%). Dose dependent prolongation of the PR interval, QRS time and the QT interval occurred in 16.32 and 20% of the cases, respectively. The adverse effects were aggravation of the arrhythmias, decrease of blood pressure and anticholinergic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mokler C, Van Arman C (1962) Pharmacology of a new antiarrhythmic agent, α-diisopropylamino-α-phenyl-α-(2-pyridil)-butyramide (SC7031). J Pharmacol Exp Ther 136: 114–124

    Google Scholar 

  2. Mathur PP (1972) Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate. Am Heart J 84: 764–770

    Google Scholar 

  3. Sekiya A, Vaughan Williams EM (1963) The effects of pronethalol, dichloriosoprenaline and disopyramide on the toxicity of the heart of ouabain and anaesthetics. Br J Pharmacol Chemother 21: 462–472

    Google Scholar 

  4. Dean RR (1975) The pharmacology of Norpace. Angiology 26: 67–84

    Google Scholar 

  5. Josephon ME, Caracta AR, Lau SH, Gallagher JJ, Damato AN (1973) Electrophysiological evaluation of disopyramide in man. Am Heart J 86: 771–780

    Google Scholar 

  6. Dreifus LS (1975) The electrophysiology of Norpace (Part I) Angiology 26: 111–115

    Google Scholar 

  7. Befeler B, Castellanos Jr A, Wells DE, Vagueiro MC, Yeh BK (1975) Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate. Am J Cardiol 35: 282–287

    Google Scholar 

  8. Dean RR Ferguson DM (1971) Effects of disopyramide on the A-V conduction system. Arch Int Pharmacodyn Ther 190: 183–189

    Google Scholar 

  9. Birkhead JS, Vaughan Williams EM (1977) Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J 39: 657–660

    Google Scholar 

  10. Danilo P, Rosen MR (1976) Cardiac effects of disopyramide. Am Heart J 92: 532–536

    Google Scholar 

  11. Desruelles J, Gerard A, Ducatillon P, Herbaux A (1967) Nos premiers essais cliniques du disopyramide (H3292) dans les troubles du rythme cardiaque. Thérapie 22: 937–944

    Google Scholar 

  12. Colonna D (1969) Disopyramide et troubles du rythme cardiaque. Gaz Med France 76: 6609–6613

    Google Scholar 

  13. Hulting J, Rosenhamer G (1976) Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia. Acta Med Scand 199: 41–51

    Google Scholar 

  14. Vogel M, Desoutter P, Bellanger Ph, Motté G, Welti JJ (1976) Action du disopyramide injectable sur les arythmies ventriculaires et sur la conduction auriculo-ventriculaire. Arch Mal Coeur 69: 395–406

    Google Scholar 

  15. Carlier J, Lisin N, Mbuyamba P (1972) Les effets hémodynamiques, toxiques et électrocardiographiques du disopyramide chez le chien, comparés à ceux provoqués par quatre autres antiarythmiques. Deuxième symposium international sur le disopyramide, Taormina, pp 63–69

  16. Befeler B (1975) The hemodynamic effects of Norpace (Part I). Angiology 26: 99–101

    Google Scholar 

  17. Willis PW (1975) The hemodynamic effects of Norpace (Part II). Angiology 26: 102–110

    Google Scholar 

  18. Vismara LA, DeMaria AN, Miller RR, Amsterdam EA, Mason DT (1975) Effects of intravenous disopyramide phosphate on cardiac function and peripheral circulation in ischemic heart disease (abstr). Clin Res 23: 87A

  19. Cardenas M, Guadalajara JF, Mendez R (1971) Primeras experiencias con disopiramida administrada por via parenteral. Arch Inst Cardiol Mex 41: 202–210

    Google Scholar 

  20. Lisin N, Andriange M, Vandenbosch R, Carlier J (1974) Traitement des troubles du rythme cardiaque par disopyramide intraveineux. Rev Méd Liège 29: 256–264

    Google Scholar 

  21. Mizgala HF, Huvelle PR (1976) Acute termination of cardiac arrhythmias with intravenous disopyramide. J Int Med Res 4 (Suppl 1): 82–85

    Google Scholar 

  22. Croxson RS (1977) A multicentre study of intravenous disopyramide in arrhythmias complicating myocardial infarction. Proceedings of the disopyramide (Ryhtmodan) seminar. St. John's College, Cambridge, pp 65–70

    Google Scholar 

  23. Valère P-E, Guerot C, Castillo Fenoy A, Branvin E, Urbanczyk A, Tricot R (1977) Action du phosphate de disopyramide injectable dans le traitement d'urgence de la tachycardie ventriculaire. Cœur Med Int 16: 285–292

    Google Scholar 

  24. Deano DA, Wu D, Mautner RK, Sherman RH, Ehsani AE, Rosen KM (1979) The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Chest 71: 597–606

    Google Scholar 

  25. Vismara LA, Vera Z, Miller RR, Mason DT (1979) Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Am J Cardiol 39: 1027–1034

    Google Scholar 

  26. Luoma PV, Kujala PA, Juustila HJ, Takkuken JT (1978) Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias. J Clin Pharmacol 18: 293–301

    Google Scholar 

  27. Marrot PK, Ruttley MST, Winterbottam JT, Muir JR (1976) A study of the acute electrophysiological and cardiovascular action of disopyramide in man. Eur J Cardiol 4: 303–312

    Google Scholar 

  28. Lambert B (1971) Intérêt de l'association acétyldigitoxine-disopyramide en traitement d'attaque de l'accès de tachyarythmie complète par fibrillation auriculaire. Marseille Med 108: 851–853

    Google Scholar 

  29. Davies GF, Joshi P, Muir JR (1977) The haemodynamic and electrophysiological effects of a combination of disopyramide and acebutalol intravenously in man. Proceedings of the disopyramide (Rhythmodan) seminar. St. John's College, Cambridge, pp 37–39

    Google Scholar 

  30. Slama R, Coumel Ph, Motté G, Gourgon R, Waynberger M, Touche S (1975) Tachycardies ventriculaires et torsades de pointe. Frontières morphologiques entre les dysrythmies ventriculaires. Arch Mal Coeur 66: 1401–1411, 1973

    Google Scholar 

  31. Slama R, Beaufils Ph, Sébastien Ph (1975) Les torsades de pointe. Rev Prat 25: 3349–3363

    Google Scholar 

  32. Jensen G, Sigurd B, Uhrenholt A (1975) Haemodynamic effects of intravenous disopyramide in heart failure. Eur J Clin Pharmacol 8: 167–173

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, Department of Internal Medicine, Brugmann Hospital, Universities of Brussels, Belgium

    M. De Backer, E. Stoupel & R. J. Kahn

Authors
  1. M. De Backer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Stoupel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. J. Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Backer, M., Stoupel, E. & Kahn, R.J. Efficacy of intravenous disopyramide in acute cardiac arrhythmias. Eur J Clin Pharmacol 19, 11–18 (1981). https://doi.org/10.1007/BF00558373

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558373

Key words

Search

Navigation